HK Stock Market Move | TRAD CHI MED (00570) fell nearly 4% after issuing a profit warning, with an expected 90%-100% decline in net profit for 2024 compared to the previous year.
Chinese traditional medicine company (00570) dropped nearly 4% after issuing a profit warning. As of the time of writing, it had dropped by 3.9% to HKD 1.97, with a turnover of HKD 152 million.
TRAD CHI MED (00570) fell by nearly 4% after issuing a profit warning, dropping by 3.9% to HK$1.97 as of the time of writing, with a turnover of HK$152 million.
On the news front, TRAD CHI MED announced that the group is expecting a 90%-100% year-on-year decline in net profit for 2024, and a 50%-60% year-on-year decrease in adjusted net profit for the current period. The board believes that the decline in net profit for the current period is mainly due to factors such as price reductions in bulk procurement, intensified market competition, and high costs of medicinal materials affecting the sales volume and profitability of the traditional Chinese medicine granule business. Additionally, impairments on credits, goodwill, and plant have increased, as well as the repayment of taxes by some of the company's subsidiaries, causing a significant impact on the group's net profit for the current period.
The adjusted net profit is the net profit after deducting the following impacts: provisions for impairments on goodwill and plant based on the current operational situation, as well as the repayment of taxes by some subsidiaries.
Related Articles

HK Stock Market Move | CSPC PHARMA (01093) rose more than 3%. Net profit fell by 10% year-on-year. Annual dividends increased by 11.5% year-on-year.

Merck & Co., Inc. (MRK.US) is close to reaching an agreement to acquire Terns Pharmaceuticals (TERN.US) to deepen their layout in the treatment of blood cancer.

Citigroup: CHINA OILFIELD (02883) Achieved Performance in Line with Expectations, Rated "Buy"
HK Stock Market Move | CSPC PHARMA (01093) rose more than 3%. Net profit fell by 10% year-on-year. Annual dividends increased by 11.5% year-on-year.

Merck & Co., Inc. (MRK.US) is close to reaching an agreement to acquire Terns Pharmaceuticals (TERN.US) to deepen their layout in the treatment of blood cancer.

Citigroup: CHINA OILFIELD (02883) Achieved Performance in Line with Expectations, Rated "Buy"

RECOMMEND

Pace Of Public Fund Issuance Slows, Hong Kong Stocks Become A Primary Focus
24/03/2026

Jensen Huang In‑Depth Interview: Token Economy Surge, AI Computing’s Share Of GDP To Multiply One Hundredfold, NVIDIA’s $10 Trillion Valuation Inevitable
24/03/2026

Are U.S.‑Iran Talks Genuine? At Minimum, Wall Street Read A Clear Signal From Trump’s Five‑Minute Rally
24/03/2026


